PBYI- Puma Biotechnology, Inc.

Across the last three months, Puma Biotechnology, Inc.'s insiders have reduced their positions by a net 44,058 shares worth roughly $364K.

PBYI sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Auerbach Alan H	7.26M	$62.38M	-
CFO	Nougues Maximo F	240.0K	$2.06M	-
Other	Hunt Douglas M	205.3K	$1.76M	-
Dir	Miller Michael Patrick	54.0K	$463.9K	-

Buys and sells only

10 filings · page 13

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Jul 2, 2021	Auerbach Alan H62	President And CEO	Sell	5,332	$8.84	$47,121.02	-0.1%	-20.5%	-68.5%
Jul 2, 2021	Nougues Maximo F61	Chief Financial Officer	Sell	155	$9.26	$1,435.11	-0.2%	-20.5%	-68.5%
Jul 2, 2021	Hunt Douglas M62	See Remarks	Sell	1,016	$9.15	$9,297.72	-1.5%	-20.5%	-68.5%
Jun 11, 2021	Senderowicz Adrian48	Director	Sell	40,993	$11.17	$457,756.53	-100%	-35.8%	-77.2%
Jun 10, 2021	Miller Ann Calby	Director	Sell	12,874	$11.43	$147,156.26	-50.0%	-36.2%	-77.3%
Jun 10, 2021	Moyes Jay M49	Director	Sell	25,248	$11.36	$286,860.20	-80.0%	-36.2%	-77.3%
Jun 10, 2021	Wilson Troy Edward64	Director	Sell	25,748	$11.36	$292,432.91	-98.7%	-36.2%	-77.3%
Jun 2, 2021	Nougues Maximo F61	Chief Financial Officer	Sell	152	$10.74	$1,632.63	-0.2%	-30.0%	-81.7%
Jun 2, 2021	Hunt Douglas M62	See Remarks	Sell	416	$10.77	$4,480.94	-0.6%	-30.0%	-81.7%
Jun 2, 2021	Auerbach Alan H62	President And CEO	Sell	1,757	$10.74	$18,877.38	-	-30.0%	-81.7%